JHOP Articles

ASCO 2026

Oncology Nursing Where It Matters Most: Inside Community Cancer Care

Original Research, Transplant, Infusion Issues, Adverse Events

Twice-Daily Bolus Versus Continuous Infusion Intravenous Tacrolimus for Prophylaxis of Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem-Cell Transplant Recipients

Sean Wilson, PharmD, MS, BCOP; Laura Beth Parsons, PharmD, BCOP; Karin Abernathy, PharmD, BCOP; Rachel Matthews, PharmD, BCOP; Darby Siler, PharmD, BCOP; Minoo Battiwalla, MD, MS

Online First

Original Research, Adverse Events, PARP Inhibitors, Dose Escalation/Reduction

Incidence of PARP Inhibitor Adverse Events Between Germline Versus Somatic Homologous Recombination Mutations

Lauren S. Yeager, PharmD, BCOP; C. Scott Ellis, PharmD, BCOP; Danielle Otto, PharmD, BCOP; Justine Pickarski, MS, LGC; Taylor A. Rives, MD; Aric Schadler, PhD, et al.

Online First

Original Research, Chronic Myeloid Leukemia, Chemotherapy, Infections, Technology

Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy: The REMEDY Pilot Study

Amber B. Clemmons, PharmD, BCOP, FHOPA; Emily Behren Ketchum, PharmD, BCOP; Stephanie Daniels, PA-C; Sarah Jimenez, DNP, AGACNP-BC, AOCNP; Mohammad Mian, MD, PhD, MPH; Locke J. Bryan, MD

Online First

Original Research, Chemotherapy, Oncology Pharmacy Programs/Protocols

Evaluation of Barriers to Initiating Chemotherapy for Pediatric Patients in the Inpatient Setting

Stephen Ensor, PharmD; Joshua Elder, PharmD, BCPS, BCOP; Kyle Harwood, PharmD, BCOP; Page Holsteen, PharmD, BCPPS

Delving Beyond the Infusion With Dr. Jennifer Brown and the AMPLIFY Trial’s Oral Breakthrough for CLL